Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

NCT02180165 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Aspergillosis

Interventions

DRUG: Posaconazole
DRUG: Voriconazole

Sponsor

Merck Sharp & Dohme LLC